title: Highlights from: 27th congress of the European Society for Medical Oncology. Nice, France. October 18-22, 2002.
authors.forename: Kavita
authors.initials: K
authors.lastname: Maung
authors.forename: David
authors.initials: D
authors.lastname: Lee
authors.forename: Heather C
authors.initials: HC
authors.lastname: DeGrendele
authors.forename: Richard
authors.initials: R
authors.lastname: Schilsky
authors.forename: Edward
authors.initials: E
authors.lastname: Chu
authors.forename: Vinay K
authors.initials: VK
authors.lastname: Jain
authors.forename: Sitki
authors.initials: S
authors.lastname: Copur
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000069287:Capecitabine; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005472:Fluorouracil / Q000008:administration & dosage; D000077156:Gefitinib; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin / Q000008:administration & dosage; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D011799:Quinazolines / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D011799:Quinazolines; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D000077146:Irinotecan; D000068818:Cetuximab; D002955:Leucovorin; D000077156:Gefitinib; D005472:Fluorouracil; D002166:Camptothecin